A research team led by Junior Associate Professor Kazuo Takayama, from the Department of Cell Growth and Differentiation, recently constructed a new model of inflammatory bowel disease using iPS cells that enables more accurate modeling of the condition for studying the underlying disease mechanisms and identifying new therapies.
This article was originally published on MedicalXpress.com